Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial - Udell, J A; Bhatt, D L; Braunwald, E (Diabetes Care, 2015)
et al.